Clinical Trial Update: Objective Assessment of Skin Damage Using ADHELASKIN in Patients With Systemic Sclerosis [NA]

View source ↗

Summary

A clinical trial investigating the objective assessment of skin damage in systemic sclerosis using ADHELASKIN; study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• ADHELASKIN

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: D013493 | NA | Status: NOT_YET_RECRUITING